The C allele of <it>JAK2 </it>rs4495487 is an additional candidate locus that contributes to myeloproliferative neoplasm predisposition in the Japanese population
<p>Abstract</p> <p>Background</p> <p>Polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF) are myeloproliferative neoplasms (MPNs) characterized in most cases by a unique somatic mutation, <it>JAK2 </it>V617F. Recent studies...
Saved in:
Main Authors: | Ohyashiki Junko H (Author), Yoneta Masayuki (Author), Hisatomi Hisashi (Author), Iwabuchi Tamiko (Author), Umezu Tomohiro (Author), Ohyashiki Kazuma (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chromatin Regulation by HP1γ Contributes to Survival of 5-Azacytidine-Resistant Cells
by: Satoshi Imanishi, et al.
Published: (2018) -
JAK2 in Myeloproliferative Neoplasms: Still a Protagonist
by: Michael Stephan Bader, et al.
Published: (2022) -
Mouse models of myeloproliferative neoplasms: JAK of all grades
by: Juan Li, et al.
Published: (2011) -
JAK2-positive Philadelphia-negative myeloproliferative neoplasms
by: Anjali Sharma, et al.
Published: (2011) -
Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms
by: Vladan P. Čokić, et al.
Published: (2015)